Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XNW5004 in Relapsed or Refractory Follicular Lymphoma (EZH2 Wild-Type)
CTR20260012Phase 2Active
- Sponsor
- Sinovent
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of igermetostat in follicular lymphoma (FL), sponsored by Sinovent. Started Feb 2026; status: active.
02
Drugs
igermetostat
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on CTR20260012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260012.